Completed OBSERVATIONAL NCT05275179

Pharmacokinetic of Posaconazole in Critically Ill Patients

Pharmacokinetic of Intravenous Posaconazole in Critically Ill Patients

Sponsor: Universitätsklinikum Hamburg-Eppendorf

Conditions Critical Illness Therapeutic Drug Monitoring

Interventions Posaconazole Therapeutic Drug Monitoring

Updated 4 times since 2022 Last updated: Nov 6, 2022 Started: Feb 11, 2021 Primary completion: Mar 30, 2022 Completion: Nov 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Critical Illness and Therapeutic Drug Monitoring and is currently completed. Universitätsklinikum Hamburg-Eppendorf leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2022 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Apr 2022 — Dec 2022 [monthly]

Recruiting

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitätsklinikum Hamburg-Eppendorf

Data source: Universitätsklinikum Hamburg-Eppendorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany